Physician profile
Todd Hansen
NPI 1215983978
$17,780.10
in general payments reported to CMS, 2019-2025
9 companies · $30.53 in 2025
The $30.53 reported for 2025 was less than what a typical Phlebology provider received nationally (typical 2025 total: $141).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $613 · 2020: $2,447 · 2021: $4,862 · 2022: $4,815 · 2023: $4,866 · 2024: $146 · 2025: $30.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $4,800 · Food and Beverage: $243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $4,800.00 |
| Food and Beverage | $242.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $17,413.33 | 2019-2023 | Venacure 1470 Pro |
| Medtronic, INC. | $133.03 | 2021-2024 | Abre |
| Tactile Systems Technology INC | $95.69 | 2020-2023 | Entre Plus, Flexitouch Plus |
| Pfizer INC. | $50.20 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $28.35 | 2024 | Xarelto |
| Smith+Nephew, INC. | $19.57 | 2021 | |
| Hartmann USA, INC. | $14.54 | 2022 | |
| Cashflow Solutions, LLC | $13.81 | 2023 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Kerecis Limited | $11.58 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Hansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.